Joint Formulary & PAD

Nepafenac - Postoperative pain and inflammation (eye)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Eye drops
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Nepafenac
Indication :
Postoperative pain and inflammation (eye)
Group Name :
Keywords :
Brand Names Include :
Nevanac
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Nepafenac is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Postoperative pain and inflammation (eye).

Committee Recommendations (1)

28 Nov 13 - ASPH DTC

The committee supported the use of nepafenac within its licensed indications. As treatment is short term postoperatively (up to 60 days with a review by the specialist 1 month post operatively) it was agreed that this would be considered as a red drug on the traffic light system.